Clinical Trials Browser

Phase 2 × Immunoconjugates × 90 days × Clear all

NCT07474558 2026-03-16

SCARLET-ICE

Phase 2 Not yet recruiting

Alopecia

NCT04829604 2026-03-09

ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)

Phase 2 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis